The global pharmacovigilance and drug safety software market is set for explosive growth, with projections indicating a surge to $359.30…
Honored for Notable Biopharmaceutical Industry Impact Honored for Notable Biopharmaceutical Industry Impact…
Press Release…
Generative AI Poised to Reinvent Life Sciences, Leading to Profound Changes in Healthcare Generative AI Poised to Reinvent Life Sciences,…
Syneos Health today appointed Collin Shannon as its new CEO. Michelle Keefe remains on Company Board and member of its…
Transaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma Customers Transaction Will Drive Ongoing Transformation…
NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Syneos Health, Inc.…
LOS ANGELES, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…
RADNOR, Pa., Sept. 19, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…
NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds…
MORRISVILLE, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization,…
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
RADNOR, Pa., Sept. 11, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…
LOS ANGELES, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…
NEW YORK, Sept. 10, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…
Syneos Health (SYNH) announces a collaboration with Chinas Wuhan Union Hospital, expanding clinical trial capabilities....…
Syneos Health (SYNH) announces shareholders approval for the impending merger and releases second-quarter 2023 financial results....…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”),…
Human Resources Leader with Nearly 30 Years of Experience and Commitment to Professional Services Environment Human Resources Leader with Nearly 30…
COMMERCIALIZATION EXPERT JOINS THE CYTOPHAGE TEAM
Winnipeg, Manitoba - TheNewswire - July 6, 2023 - Cytophage Technologies Inc., a Canadian biotech…
Syneos Health (SYNH) partners with uMotif to deliver the patient-centric eClinical platform....…
Integrated eCOA & ePRO Solution Taps Companys Decentralized Capabilities and Technology Expertise Integrated eCOA & ePRO Solution Taps Companys Decentralized Capabilities and…
Syneos Health (SYNH) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…
Syneos Healths (SYNH) purchase price represents a 24% premium to its unaffected closing stock price prior to the announcement. Margin…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Newly Created Role Demonstrates Commitment to Improve Diversity in Clinical Trials and Commercialization Across Organization Newly Created Role Demonstrates Commitment to…
Healthcare Businesswomens Association Spotlights Jennifer Sozio and Caitlin Purinai for Biopharma Industry Impact Healthcare Businesswomens Association Spotlights Jennifer Sozio and…
Latest Ratings for SYNH
DateFirmActionFromTo Mar 2022MizuhoMaintainsBuy Jan 2022BarclaysMaintainsOverweight Dec 2021CitigroupDowngradesBuyNeutral
View More Analyst Ratings…
Latest Ratings for SYNH
DateFirmActionFromTo Mar 2022MizuhoMaintainsBuy Jan 2022BarclaysMaintainsOverweight Dec 2021CitigroupDowngradesBuyNeutral
View More Analyst Ratings…
Company Executives Honored for Notable Biopharmaceutical Industry Impact Company Executives Honored for Notable Biopharmaceutical Industry Impact...…
Syneos Healths (SYNH) first-quarter 2023 earnings and revenues beat estimates. The company enters into a definitive merger agreement to be…
Syneos Health (SYNH) is set to become private company following a $7.1 billion merger deal to be acquired by a…
Nach den Inflationsdaten für April zeichnet sich am Mittwoch ein leichtes Plus an der Wall Street ab. Der Leitindex Dow…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization,…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
...(Reuters) - An investment consortium, comprising of Elliott......…
... (Reuters) - An investment consortium, comprising
of Elliott Investment......…
Syneos Health Inc.’s stock SYNH soared 9% in premarket trade Wednesday, after the biopharma services company said it has agreed…
...May 10 (Reuters) - An investment consortium, comprising
of Elliott......…
Shareholders to Receive $43.00 Per Share in Cash...…
...(Adds deal price, details)
By Anirban Sen
NEW YORK, May 9 (Reuters..., the last trading day before Reuters reported
that the company......…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…